Intelligent Stimuli-responsive Nano Immunomodulators for Cancer Immunotherapy

Overview

Journal Chem Sci

Publisher Royal Society of Chemistry

Specialty Chemistry

Date 2021 Jun 24

PMID 34164080

Citations 9

Authors

Yanhua Li

Xia Zhang

Xiaohan Liu

Wei Pan

Na Li

Bo Tang

Affiliations

Soon will be listed here.

Abstract

Cancer immunotherapy is a revolutionary treatment method in oncology, which uses a human's own immune system against cancer. Many immunomodulators that trigger an immune response have been developed and applied in cancer immunotherapy. However, there is the risk of causing an excessive immune response upon directly injecting common immunomodulators into the human body to trigger an immune response. Therefore, the development of intelligent stimuli-responsive immunomodulators to elicit controlled immune responses in cancer immunotherapy is of great significance. Nanotechnology offers the possibility of designing smart nanomedicine to amplify the antitumor response in a safe and effective manner. Progress relating to intelligent stimuli-responsive nano immunomodulators for cancer immunotherapy is highlighted as a new creative direction in the field. Considering the clinical demand for cancer immunotherapy, we put forward some suggestions for constructing new intelligent stimuli-responsive nano immunomodulators, which will advance the development of cancer immunotherapy.

Citing Articles

Smart delivery vehicles for cancer: categories, unique roles and therapeutic strategies.

Zeng Y, Gao Y, He L, Ge W, Wang X, Ma T Nanoscale Adv. 2024; 6(17):4275-4308.

PMID: 39170969 PMC: 11334973. DOI: 10.1039/d4na00285g.

Red and near-infrared light-activated photoelectrochemical nanobiosensors for biomedical target detection.

Monsalve Y, Cruz-Pacheco A, Orozco J Mikrochim Acta. 2024; 191(9):535.

PMID: 39141139 PMC: 11324696. DOI: 10.1007/s00604-024-06592-x.

Multistage Self-Assembled Nanomaterials for Cancer Immunotherapy.

Guo L, Yang J, Wang H, Yi Y Molecules. 2023; 28(23).

PMID: 38067480 PMC: 10707962. DOI: 10.3390/molecules28237750.

Emerging Strategies for Immunotherapy of Solid Tumors Using Lipid-Based Nanoparticles.

Fernandes S, Cassani M, Cavalieri F, Forte G, Caruso F Adv Sci (Weinh). 2023; 11(8):e2305769.

PMID: 38054651 PMC: 10885677. DOI: 10.1002/advs.202305769.

Integrative profiling analysis reveals prognostic significance, molecular characteristics, and tumor immunity of angiogenesis-related genes in soft tissue sarcoma.

Liu B, Li C, Feng C, Wang H, Zhang H, Tu C Front Immunol. 2023; 14:1178436.

PMID: 37377953 PMC: 10291125. DOI: 10.3389/fimmu.2023.1178436.

References

Han S, Huang K, Gu Z, Wu J . Tumor immune microenvironment modulation-based drug delivery strategies for cancer immunotherapy. Nanoscale. 2019; 12(2):413-436. DOI: 10.1039/c9nr08086d. View

Hansel T, Kropshofer H, Singer T, Mitchell J, George A . The safety and side effects of monoclonal antibodies. Nat Rev Drug Discov. 2010; 9(4):325-38. DOI: 10.1038/nrd3003. View

Delpech B, Laquerriere A, Maingonnat C, Bertrand P, Freger P . Hyaluronidase is more elevated in human brain metastases than in primary brain tumours. Anticancer Res. 2002; 22(4):2423-7. View

Postow M, Sidlow R, Hellmann M . Immune-Related Adverse Events Associated with Immune Checkpoint Blockade. N Engl J Med. 2018; 378(2):158-168. DOI: 10.1056/NEJMra1703481. View

Wen Y, Chen X, Zhu X, Gong Y, Yuan G, Qin X . Photothermal-Chemotherapy Integrated Nanoparticles with Tumor Microenvironment Response Enhanced the Induction of Immunogenic Cell Death for Colorectal Cancer Efficient Treatment. ACS Appl Mater Interfaces. 2019; 11(46):43393-43408. DOI: 10.1021/acsami.9b17137. View

Liang X, Li X, Duan J, Chen Y, Wang X, Pang L . Nanoparticles with CD44 Targeting and ROS Triggering Properties as Effective in Vivo Antigen Delivery System. Mol Pharm. 2018; 15(2):508-518. DOI: 10.1021/acs.molpharmaceut.7b00890. View

Liu D, Chen B, Mo Y, Wang Z, Qi T, Zhang Q . Redox-Activated Porphyrin-Based Liposome Remote-Loaded with Indoleamine 2,3-Dioxygenase (IDO) Inhibitor for Synergistic Photoimmunotherapy through Induction of Immunogenic Cell Death and Blockage of IDO Pathway. Nano Lett. 2019; 19(10):6964-6976. DOI: 10.1021/acs.nanolett.9b02306. View

Zheng D, Chen J, Zhu J, Rong L, Li B, Lei Q . Highly Integrated Nano-Platform for Breaking the Barrier between Chemotherapy and Immunotherapy. Nano Lett. 2016; 16(7):4341-7. DOI: 10.1021/acs.nanolett.6b01432. View

Liu Y, Bhattarai P, Dai Z, Chen X . Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer. Chem Soc Rev. 2018; 48(7):2053-2108. PMC: 6437026. DOI: 10.1039/c8cs00618k. View

10.

Dai L, Li X, Yao M, Niu P, Yuan X, Li K . Programmable prodrug micelle with size-shrinkage and charge-reversal for chemotherapy-improved IDO immunotherapy. Biomaterials. 2020; 241:119901. DOI: 10.1016/j.biomaterials.2020.119901. View

11.

Rai P, Young J, Burton D, Giribaldi M, Onder T, Weinberg R . Enhanced elimination of oxidized guanine nucleotides inhibits oncogenic RAS-induced DNA damage and premature senescence. Oncogene. 2010; 30(12):1489-96. DOI: 10.1038/onc.2010.520. View

12.

Kaiser J, Couzin-Frankel J . Cancer immunotherapy sweeps Nobel for medicine. Science. 2018; 362(6410):13. DOI: 10.1126/science.362.6410.13. View

13.

Sahin U, Tureci O . Personalized vaccines for cancer immunotherapy. Science. 2018; 359(6382):1355-1360. DOI: 10.1126/science.aar7112. View

14.

Gajewski T, Meng Y, Blank C, Brown I, Kacha A, Kline J . Immune resistance orchestrated by the tumor microenvironment. Immunol Rev. 2006; 213:131-45. DOI: 10.1111/j.1600-065X.2006.00442.x. View

15.

Kleinovink J, Fransen M, Lowik C, Ossendorp F . Photodynamic-Immune Checkpoint Therapy Eradicates Local and Distant Tumors by CD8 T Cells. Cancer Immunol Res. 2017; 5(10):832-838. DOI: 10.1158/2326-6066.CIR-17-0055. View

16.

Byun D, Wolchok J, Rosenberg L, Girotra M . Cancer immunotherapy - immune checkpoint blockade and associated endocrinopathies. Nat Rev Endocrinol. 2017; 13(4):195-207. PMC: 5629093. DOI: 10.1038/nrendo.2016.205. View

17.

Zhang J, Endres S, Kobold S . Enhancing tumor T cell infiltration to enable cancer immunotherapy. Immunotherapy. 2019; 11(3):201-213. DOI: 10.2217/imt-2018-0111. View

18.

Bohme I, Bosserhoff A . Acidic tumor microenvironment in human melanoma. Pigment Cell Melanoma Res. 2016; 29(5):508-23. DOI: 10.1111/pcmr.12495. View

19.

Chang H, Zou Z, Wang Q, Li J, Jin H, Yin Q . Targeting and Specific Activation of Antigen-Presenting Cells by Endogenous Antigen-Loaded Nanoparticles Elicits Tumor-Specific Immunity. Adv Sci (Weinh). 2020; 7(1):1900069. PMC: 6947714. DOI: 10.1002/advs.201900069. View

20.

Zhang Z, Wang Q, Liu Q, Zheng Y, Zheng C, Yi K . Dual-Locking Nanoparticles Disrupt the PD-1/PD-L1 Pathway for Efficient Cancer Immunotherapy. Adv Mater. 2019; 31(51):e1905751. DOI: 10.1002/adma.201905751. View